Francisco David
Rodríguez García
Profesor Titular de Universidad
Instituto de Neurociencias de Castilla y León
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Neurociencias de Castilla y León (11)
2023
-
Association of Neurokinin-1 Receptor Signaling Pathways with Cancer
Current Medicinal Chemistry, Vol. 31
-
Involvement of the Opioid Peptide Family in Cancer Progression
Biomedicines, Vol. 11, Núm. 7
-
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies
International Journal of Molecular Sciences, Vol. 24, Núm. 12
-
Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families
Cancers, Vol. 15, Núm. 6
-
Peptidergic Systems as Antitumor Targets: A Right Direction to Fight Cancer?
Cancers
-
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant
International Journal of Molecular Sciences, Vol. 24, Núm. 21
2021
-
Biochemical mechanisms associating alcohol use disorders with cancers
Cancers, Vol. 13, Núm. 14
2017
-
Targeting NPY, CRF/UCNS and NPS neuropeptide systems to treat alcohol use disorder (AUD)
Current Medicinal Chemistry, Vol. 24, Núm. 23, pp. 2528-2558
2013
-
GEMSP exerts a myelin-protecting role in the rat optic nerve
Neurological Research, Vol. 35, Núm. 9, pp. 903-911
2011
-
Targeting opioid and neurokinin-1 receptors to treat alcoholism
Current Medicinal Chemistry, Vol. 18, Núm. 28, pp. 4321-4334